Blood Thinner Drug Xarelto Linked to Serious Bleeding Events
The Tampa injury attorneys at Alley, Clark & Greiwe are investigating claims of persons severely injured while taking the blood thinner Xarelto. Xarelto (rivaroxaban) is a relatively new drug developed by Janssen Pharmaceuticals and Bayer. The drug was approved for sale in the U.S. by the FDA in 2011. It is prescribed to treat or prevent blood clots including deep vein thrombosis (DVT) and pulmonary embolism. Xarelto is also prescribed to patients with atrial fibrillation (a heart rhythm disorder) to lower the risk of stroke.
Xarelto is an alternative to Coumadin (warfarin). While patients on Coumadin require frequent lab monitoring and dose adjustments, patients on Xarelto do not. It is this advantage that has been a key selling point. However, Xarelto has been linked to serious bleeding events including hemorrhage, GI bleeds, and even death. The additional problem with Xarelto is the absence of an approved reversal agent or antidote that can stop uncontrollable, sometimes fatal, bleeding. This is a similar problem linked to another newer-generation blood thinner called Pradaxa (dabigatran) which was subject to widespread litigation in the US.
If you are presently taking Xarelto, please call your health care provider immediately if you develop any of the following signs or symptoms of bleeding:
Contact a Tampa Xarelto Attorney
If you or a loved one have suffered a stroke, heart attack, brain bleed, gastrointestinal bleed, or death while taking Xarelto, please contact Alley, Clark & Greiwe to speak with an attorney about your legal rights.
Xarelto Litigation Proceedings
Claims involving Xarelto are considered a "mass tort." Mass tort claims involve numerous injured persons harmed by the same product or event. Previous examples of mass tort claims include recalled hip implants, or recalled drug products like Vioxx, the diet drug combination fen-phen, or hormone replacement therapy (HRT) litigation, just to name a few. Events like exploding airbags, airline crashes, and oil spills are considered mass torts.
Mass torts are not the same as a "class action" which is a common misconception. In many instances a mass tort is litigated in what is called multi-district litigation (MDL). This type of centralized litigation is not the same as a class action. Unlike a class action, individual lawsuits filed all across the United States remain stand-alone lawsuits, but they will be transferred to one jurisdiction and assigned to one federal court judge. Product liability cases are often good candidates for MDL because they involve a large number of people similarly injured by a particular product. The MDL process is a mechanism that allows the pretrial procedures of numerous similar cases to be consolidated before a single judge, with the intention of avoiding inconsistent rulings, completing generic discovery and conserving the resources of the parties involved. The Judicial Panel on Multi-District Litigation (JPMDL) chose the Honorable Eldon Fallon, a federal court judge in the United States District Court for the Eastern District of Louisiana is presiding over the Xarelto Products Liability Litigation MDL proceedings.
The experienced mass tort attorneys at Alley, Clark & Greiwe are presently accepting claims of persons who have suffered a stroke, heart attack, brain bleed, gastrointestinal bleed, or death while taking Xarelto. For nearly three decades, our Tampa attorneys have successfully represented thousands of injured persons throughout the State of Florida in various complex product liability and mass tort claims against the makers of dangerous drugs and unsafe medical products. These cases have involved claims against diet drug manufacturers, hormone replacement therapy, big tobacco, breast implant manufacturers, as well as claims involving Baycol, Vioxx, Bextra, ProtoGen bladder slings, and various hip and knee implant manufacturers.